A Phase I Trial of Combination Bryostatin 1 (NSC 339555) and Vincristine in B-Cell Malignancies
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2010
At a glance
- Drugs Bryostatin-1 (Primary) ; Vincristine
- Indications Chronic lymphocytic leukaemia; Multiple myeloma; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 18 Apr 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 04 Sep 2005 New trial record.